Search for: "More v. Collection Professionals Inc et al" Results 101 - 120 of 125
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Mar 2011, 7:00 am by Kara OBrien
Generally, the examination team will consist of at least two examiners, but often includes five or more. [read post]
10 Feb 2011, 7:32 am by Christopher G. Hill
Thor, Inc., et al., the Court, among other rulings, allowed the defendant to collect its attorney fees because Thor had such a provision in its contract. [read post]
19 Jan 2011, 6:02 am by stevemehta
Wasserman, Comden, Casselman & Pearson, L.L.P., et al., Super. [read post]
29 Jun 2010, 1:34 am by stevemehta
SOMA ENVIRONMENTAL ENGINEERING, INC., et al., Defendants and Respondents. [read post]
1 Jun 2010, 1:51 pm
 The Supreme Court’s ruling in American Needle, Inc. v. [read post]
24 Nov 2009, 10:30 am
Willets Point United, Inc.; Institute for Justice; City of New York; Fifth Avenue Committee et al., amici curiae. [read post]
16 Oct 2009, 3:18 pm
When a claim may have more than one reasonable interpretation, we recommend that a firm have substantiation for each interpretation. [read post]
16 Oct 2009, 10:33 am by Joe Mullin
Foley & Lardner, which represented DataTern in the suit, claims it is still owed more than $1.5 million in fees for its work on the case. [read post]
18 Jul 2009, 7:31 am
In addition, in an effort to bring cases more quickly, the SEC has also more frequently filed these cases in the ab [read post]
12 Jan 2009, 4:06 am
Banc of America Investment Services, Inc. et al.NJNEWSTeaneck establishing employment discrimination committee? [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
8 Jan 2008, 6:53 am
  (26-CA-22031, et al.; 351 NLRB No. 74) Grenada, MS Dec. 21, 2007. [read post]
12 Oct 2007, 9:14 am
Cullen issued his decision Feb. 20, 2003. *** BE&K Construction Co. (32-CA-9479, et al.; 351 NLRB No. 29) Pittsburg, CA Sept. [read post]
24 Sep 2007, 4:38 pm
Parke issued her decision May 15, 2003. *** Exceptional Professional, Inc. d/b/a EPI Construction (17-CA-19272, et al.; 350 NLRB No. 81) Nixa, MO Aug. 28, 2007. [read post]
15 Sep 2007, 7:49 pm
Given that men who fail to complete treatment are younger, less educated, and more antisocial than treatment completers (Wierzbicki & Pekarik, 1993), critics have interpreted Hall's study as further evidence of the stability of individual differences in recidivism potential (Harris et al., 1998).In the next major meta-analysis, Gallagher et al. (1999) examined 22 studies (25 treatment comparisons). [read post]